EMIS | Search

Trials

First posted Mar 29, 2011

Completed

NCT05169723

Respiratory Emissions in Healthy Participants

40 participants · First posted Dec 27, 2021

Completed

NCT06326866

Otoacoustic Emissions in Different Blood Types

70 participants · First posted Mar 22, 2024

Drugs

View all 50 →

Insulin oral(Emisphere Technologies, Inc.)

Small Molecule

Approved

Ammonia N-13(Ammonia N 13)

Conditions: Coronary Artery Disease (CAD)

H₃N

EGIS-6877

Organizations

View all 7 →

Emisphere Technologies, Inc.

United States

Birchtech Corp

China

EMEIS COSMETICS PTY. LTD.

Australia

News

View all 243 →

last year

EMIS Wins Innovation Award for Revolutionary Clinical Trial Recruitment Platform

last year

Novartis Launches Zero-Interest Payment Plan for High-Cost Cholesterol Drug Inclisiran in India

last year

Trials

Interrelations Between Spontaneous Otoacoustic Emissions and Transient Evoked Emissions

Respiratory Emissions in Healthy Participants

Otoacoustic Emissions in Different Blood Types

Drugs

Insulin oral(Emisphere Technologies, Inc.)

Ammonia N-13(Ammonia N 13)

EGIS-6877

Organizations

Emisphere Technologies, Inc.

Birchtech Corp

EMEIS COSMETICS PTY. LTD.

News

EMIS Wins Innovation Award for Revolutionary Clinical Trial Recruitment Platform

Novartis Launches Zero-Interest Payment Plan for High-Cost Cholesterol Drug Inclisiran in India

Persistent Tumor Hypoxia Predicts Distant Metastasis in Head and Neck Cancer